Salvacyl: new treatment for male sexual deviation

Salvacyl (triptorelin) is a new long-acting treatment for men with severe sexual deviations.

It is administered every 12 weeks as a single 11.25mg intramuscular injection.

Triptorelin is a GnRH agonist. It lessens sexual drive by inhibiting secretion of LH and FSH, thereby reducing testosterone production. Other preparations of triptorelin are used to treat precocious puberty, endometriosis and prostate cancer.

Treatment with Salvacyl should be initiated and monitored by a psychiatrist, and must be given in combination with psychotherapy.

View Salvacyl drug record

Further information: Ipsen

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more